Elizabeth H.z. Thompson - 04 Jan 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
EVP, Research & Development
Signature
/s/ Adriana Hernandez-Capone, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
04 Jan 2023
Net transactions value
$0
Form type
4
Filing time
06 Jan 2023, 16:43:23 UTC
Previous filing
04 Jan 2023
Next filing
14 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units (RSU) Award $0 +20,697 $0.000000 20,697 04 Jan 2023 Ordinary Shares 20,697 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one ordinary share of the Issuer.
F2 The RSUs vest 1/3rd annually on each anniversary of January 5, 2023.